Metastatic Esophageal Adenocarcinoma

Also known as: Metastatic Oesophageal Adenocarcinoma / Oesophageal adenocarcinoma metastatic / Metastatic Adenocarcinoma of the Esophagus / Esophageal adenocarcinoma metastatic / Esophageal adenocarcinoma site unspecified stage IV / Oesophageal adenocarcinoma site unspecified stage IV / Oesophageal adenocarcinoma stage IV / Esophageal adenocarcinoma stage IV / Esophageal adenocarcinoma / Oesophageal adenocarcinoma NOS / Adenocarcinoma of esophagus / Adenocarcinoma of esophagus (disorder) / Adenocarcinoma of oesophagus / Oesophageal adenocarcinoma

DrugDrug NameDrug Description
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DrugDrug NamePhaseStatusCount
DB11740Adavosertib1Active Not Recruiting1
DB12001Abemaciclib1 / 2Unknown Status1
DB05578Ramucirumab1 / 2Unknown Status1
DB15676Balstilimab2Recruiting1
DB16651Botensilimab2Recruiting1
DB12250Cixutumumab2Active Not Recruiting1
DB00530Erlotinib2Completed1
DB00544Fluorouracil2Completed1
DB00544Fluorouracil2Recruiting1
DB00650Leucovorin2Completed1
DB00650Leucovorin2Recruiting1
DB00526Oxaliplatin2Completed1
DB00526Oxaliplatin2Recruiting1
DB01229Paclitaxel2Active Not Recruiting1
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Recruiting1
DB00571Propranolol2Recruiting1
DB05578Ramucirumab2Recruiting1
DB06599Lexatumumab2 / 3Recruiting1
DB09035Nivolumab2 / 3Recruiting1
DB01229Paclitaxel2 / 3Recruiting1
DB05578Ramucirumab2 / 3Recruiting1
DB01373Calcium3Recruiting1
DB01101Capecitabine3Recruiting1
DB00544Fluorouracil3Recruiting2
DB00762Irinotecan3Recruiting1
DB00650Leucovorin3Recruiting2
DB11596Levoleucovorin3Recruiting1
DB09035Nivolumab3Recruiting1
DB00526Oxaliplatin3Recruiting2